|
⚲
|
| Keyboard |
| Mette Agger | |
|---|---|
| Firm | |
| Address | 700 Technology Square 3rd Floor Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Imara Inc | 021-336073 | Director | 44.1 M of 63.0 M |
||
| Tiburio Therapeutics Inc | 021-329946 | Director | 5.0 M of 31.0 M |
||
| Cydan II Inc | 021-296407 | Director | 10.7 M of 34.0 M |
||
| Trevi Therapeutics Inc | 021-291383 | Director | 51.9 M of 61.9 M |
||
| scPharmaceuticals Inc | 021-277857 | Director | 47.0 M of 47.0 M |
||
| scPharmaceuticals Inc | 021-270108 | Director | 4.0 M of 10.0 M |
||
| scPharmaceuticals Inc | 021-270107 | Director | 8.2 M of 8.2 M |
||
| Imara Inc | 021-261834 | Director | 6.0 M of 31.0 M |
||
| scPharmaceuticals Inc | 021-256791 | Director | 3.6 M of 7.5 M |
||
| scPharmaceuticals Inc | 021-215061 | Director | 9.1 M of 17.1 M |
||
| Thesan Pharmaceuticals Inc | 021-212387 | Director | 17.4 M of 49.5 M |
||
| Allocure Inc | 021-176419 | Director | 26.5 M of 26.5 M |
||